Harmony Biosciences Holdings, Inc.
HRMY- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001802665
In the last 90 days, Harmony Biosciences Holdings, Inc. insiders filed 0 open-market purchases and 2 sales; 328 institutions reported holding it in 13F filings for Q2 2026, worth $1.97B in total; no superinvestor holds it.
13F holders, Q3 2025
Institutional positions in Harmony Biosciences Holdings, Inc. as of Sep 30, 2025. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 296
- +19 vs. Q2 2025
- Shares held
- 47.4M
- −3.84M (−7.5%) vs. Q2 2025
- Total value
- $1.31B
- −$313.1M (−19.3%) vs. Q2 2025
- New holders
- 44
- 116 more added
- Sold out
- 25
- 88 more reduced
2 institutions that held it in Q2 2025 haven't filed for Q3 2025 yet. Not filing isn't selling, so they aren't counted as sold out or in the changes above.
Compare with Q2 2025: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HRMY on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 328 | $1.97B |
| Q1 2026 | 311 | $1.57B |
| Q4 2025 | 325 | $1.87B |
| Q3 2025 | 296 | $1.31B |
| Q2 2025 | 279 | $1.62B |
| Q1 2025 | 272 | $1.67B |
| Q4 2024 | 247 | $1.82B |
| Q3 2024 | 234 | $2.01B |
| Q2 2024 | 219 | $1.51B |
| Q1 2024 | 207 | $1.64B |
| Q4 2023 | 221 | $1.54B |
| Q3 2023 | 205 | $1.62B |
| Q2 2023 | 211 | $1.83B |
| Q1 2023 | 218 | $1.68B |
| Q4 2022 | 242 | $2.81B |
| Q3 2022 | 203 | $2.24B |
| Q2 2022 | 184 | $2.34B |
| Q1 2022 | 182 | $2.26B |
| Q4 2021 | 147 | $1.90B |
| Q3 2021 | 102 | $1.19B |
| Q2 2021 | 84 | $790.3M |
| Q1 2021 | 57 | $907.6M |
Institutions, Q3 2025
Shares, value and share of portfolio for each institution holding Harmony Biosciences Holdings, Inc.; share changes are against Q2 2025.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Rice Hall James & Associates, LLC | 0 | $0 | 0.00% | −76,287−100.0% | Sold out |
| Weiss Asset Management LP | 0 | $0 | 0.00% | −58,102−100.0% | Sold out |
| Point72 Asset Management, L.P. | 0 | $0 | 0.00% | −33,778−100.0% | Sold out |
| Paloma Partners Management Co | 0 | $0 | 0.00% | −29,617−100.0% | Sold out |
| Qube Research & Technologies Ltd | 0 | $0 | 0.00% | −25,231−100.0% | Sold out |
| Nebula Research & Development LLC | 0 | $0 | 0.00% | −17,403−100.0% | Sold out |
| StoneX Group Inc. | 0 | $0 | 0.00% | −13,347−100.0% | Sold out |
| Maryland State Retirement & Pension System | 0 | $0 | 0.00% | −11,165−100.0% | Sold out |
| Prairiewood Capital, LLC | 0 | $0 | 0.00% | −10,483−100.0% | Sold out |
| Quantbot Technologies LP | 0 | $0 | 0.00% | −10,311−100.0% | Sold out |
| Susquehanna Portfolio Strategies, LLC | 0 | $0 | 0.00% | −9,270−100.0% | Sold out |
| Hohimer Wealth Management, LLC | 0 | $0 | 0.00% | −8,252−100.0% | Sold out |
| Amundi | 0 | $0 | 0.00% | −6,373−100.0% | Sold out |
| Skopos Labs, Inc. | 0 | $0 | 0.00% | −1,288−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −1,172−100.0% | Sold out |
| Financial Management Professionals, Inc. | 0 | $0 | 0.00% | −867−100.0% | Sold out |
| Bayforest Capital Ltd | 0 | $0 | 0.00% | −588−100.0% | Sold out |
| Harbor Capital Advisors, Inc. | 0 | $0 | 0.00% | −229−100.0% | Sold out |
| Aster Capital Management (DIFC) Ltd | 0 | $0 | 0.00% | −152−100.0% | Sold out |
| Bryn Mawr Trust Co | 0 | $0 | 0.00% | −146−100.0% | Sold out |
| Larson Financial Group LLC | 0 | $0 | 0.00% | −3−100.0% | Sold out |
| Norges Bank | – | – | – | – | Not filed |
| Parkworth Wealth Management, Inc. | – | – | – | – | Not filed |